Want to see BLMH full AI Analyst Report?
Top Page
Blum Holdings
(OTC:BLMH)
Select Model
Select Model
Rating:47Neutral
Price Target:
$0.23
▲(10.00% Upside)
Action:Reiterated
Date:08/25/26
The score is held down primarily by weak financial performance—deep operating/net losses, negative equity, and ongoing negative free cash flow raise financing and dilution risk. Technicals provide only modest support (trading above shorter-term averages with neutral momentum), while valuation is constrained by negative earnings and no dividend yield.
Positive Factors
Gross Margin
Gross margin near 44% indicates the retail offering retains meaningful product-level economics. If maintained, this provides a base for operating leverage, although the current cost structure absorbs that margin and the company remains far from breakeven.
Negative Factors
Deep Operating and Net Losses
The magnitude of operating and net losses indicates that gross profit is insufficient to cover the company’s cost structure. Persistent losses weaken earnings quality, increase dependence on external funding, and make a durable path to breakeven uncertain.
Read all positive and negative factors
Positive Factors
Negative Factors
Gross Margin
Gross margin near 44% indicates the retail offering retains meaningful product-level economics. If maintained, this provides a base for operating leverage, although the current cost structure absorbs that margin and the company remains far from breakeven.
Read all positive factors
Blum Holdings (BLMH) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$5.83M
Dividend YieldN/A
Average Volume (3M)2.87K
Price to Earnings (P/E)―
Beta (1Y)1.96
Revenue Growth19.98%
EPS Growth-180.06%
CountryUS
Employees133
SectorHealthcare
Sector Strength45
IndustrySpecialty Retail
Share Statistics
EPS (TTM)-0.35
Shares Outstanding31,528,812
10 Day Avg. Volume2,994
30 Day Avg. Volume2,867
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)-1.14
Price to Sales (P/S)0.55
P/FCF Ratio-3.22
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Blum Holdings Business Overview & Revenue Model
Company Description
Blum Holdings, Inc. is an entity operating within California's regulated cannabis market, comprehensively addressing both medical and adult-use demands. The company's multifaceted involvement encompasses the cultivation, production, distribution, ...
Blum Holdings Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
12
Very Negative
Cash Flow
16
Very Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Mar 2024 | Dec 2022 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.76M | 14.91M | 12.99M | 33.23M | 52.02M | 42.12M |
| Gross Profit | 6.59M | 6.00M | 6.21M | 14.00M | 16.90M | 11.02M |
| EBITDA | -6.31M | -6.30M | 22.00M | -2.26M | -171.57M | -30.07M |
| Net Income | -9.39M | -7.96M | 33.10M | -14.13M | -188.93M | -31.27M |
Balance Sheet | ||||||
| Total Assets | 43.57M | 44.52M | 24.82M | 32.07M | 40.51M | 271.82M |
| Cash, Cash Equivalents and Short-Term Investments | 590.00K | 813.00K | 1.04M | 862.00K | 1.20M | 6.70M |
| Total Debt | 7.94M | 7.50M | 4.79M | 37.70M | 49.56M | 79.41M |
| Total Liabilities | 51.67M | 48.74M | 29.56M | 77.77M | 77.05M | 125.34M |
| Stockholders Equity | -11.05M | -7.17M | -6.75M | -45.70M | -36.54M | 142.63M |
Cash Flow | ||||||
| Free Cash Flow | -2.45M | -2.53M | -2.15M | -1.29M | -9.76M | -21.93M |
| Operating Cash Flow | -2.43M | -2.50M | -2.14M | -965.00K | -7.83M | -17.96M |
| Investing Cash Flow | 65.00K | -971.00K | 2.03M | 462.00K | 19.61M | 21.67M |
| Financing Cash Flow | 2.59M | 3.25M | 143.00K | 539.00K | -17.27M | 4.50M |
Blum Holdings Technical Analysis
Negative
0.21
Price Trends
0.20
Negative
0.22
Negative
0.34
Negative
Market Momentum
>-0.01
Positive
46.18
Neutral
53.28
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BLMH, the sentiment is Negative. The current price of 0.21 is above the 20-day moving average (MA) of 0.21, above the 50-day MA of 0.20, and below the 200-day MA of 0.34, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 46.18 is Neutral, neither overbought nor oversold. The STOCH value of 53.28 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for BLMH.
Blum Holdings Risk Analysis
Blum Holdings disclosed 56 risk factors in its most recent earnings report. Blum Holdings reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Blum Holdings Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
47 Neutral | $5.83M | -0.52 | -140.00% | ― | 19.98% | -180.06% | |
45 Neutral | $6.27M | -1.07 | -88.38% | ― | 47.00% | 50.49% | |
44 Neutral | $5.60M | -1.63 | -33.59% | ― | 10.01% | 95.01% | |
42 Neutral | $2.92M | -0.03 | -56.96% | ― | ― | ― | |
42 Neutral | $2.11M | -1,062.50 | -3.03% | ― | -11.91% | -285.23% | |
37 Underperform | $24.15M | -0.52 | -148.91% | ― | -18.24% | -2264.65% |
* Healthcare Sector Average
BLMH
Blum Holdings
0.19
-0.45
-71.00%
SNOA
Sonoma Pharmaceuticals
1.31
-3.40
-72.19%
AYTU
Aytu BioScience
2.25
-0.10
-4.26%
YCBD
cbdMD
0.50
-0.23
-31.51%
PRFX
PainReform
0.96
-6.29
-86.74%
IMCC
IM Cannabis Corp
3.41
-66.19
-95.10%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.